Mission Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
4,461
+14
+0.3% +$3.48K 0.02% 310
2025
Q4
$1.22M Sell
4,447
-77
-2% -$21.1K 0.02% 295
2025
Q3
$1.19M Buy
4,524
+385
+9% +$93.6K 0.02% 303
2025
Q2
$906K Buy
4,139
+95
+2% +$20.3K 0.02% 350
2025
Q1
$905K Sell
4,044
-141
-3% -$38.9K 0.02% 330
2024
Q4
$1.37M Sell
4,185
-64
-2% -$20.1K 0.03% 229
2024
Q3
$1.28M Sell
4,249
-587
-12% -$180K 0.03% 242
2024
Q2
$1.59M Buy
4,836
+463
+11% +$164K 0.04% 195
2024
Q1
$1.73M Sell
4,373
-158
-3% -$58.4K 0.05% 202
2023
Q4
$1.6M Buy
4,531
+114
+3% +$40.3K 0.05% 174
2023
Q3
$1.66M Buy
4,417
+25
+0.6% +$9.67K 0.06% 152
2023
Q2
$1.68M Sell
4,392
-40
-0.9% -$14.3K 0.06% 151
2023
Q1
$1.54M Buy
4,432
+233
+6% +$68.1K 0.07% 163
2022
Q4
$988K Buy
4,199
+237
+6% +$56.2K 0.05% 204
2022
Q3
$975K Buy
3,962
+108
+3% +$32.9K 0.05% 192
2022
Q2
$1.17M Buy
3,854
+714
+23% +$232K 0.06% 173
2022
Q1
$1.29M Buy
3,140
+308
+11% +$121K 0.06% 164
2021
Q4
$1.33M Sell
2,832
-52
-2% -$22.4K 0.06% 158
2021
Q3
$1.22M Sell
2,884
-268
-9% -$113K 0.06% 155
2021
Q2
$1.13M Sell
3,152
-43
-1% -$14.2K 0.06% 157
2021
Q1
$900K Buy
3,195
+291
+10% +$83.3K 0.05% 160
2020
Q4
$823K Buy
2,904
+461
+19% +$129K 0.05% 158
2020
Q3
$672K Sell
2,443
-146
-6% -$38.6K 0.05% 163
2020
Q2
$588K Buy
2,589
+69
+3% +$13.6K 0.05% 163
2020
Q1
$384K Sell
2,520
-57
-2% -$8.77K 0.04% 184
2019
Q4
$387K Buy
2,577
+39
+2% +$5.68K 0.04% 209
2019
Q3
$360K Sell
2,538
-130
-5% -$17.9K 0.04% 202
2019
Q2
$334K Buy
2,668
+62
+2% +$7.32K 0.04% 223
2019
Q1
$287K Buy
2,606
+226
+9% +$23.5K 0.03% 233
2018
Q4
$233K Buy
+2,380
New +$258K 0.03% 235

Other funds holding WST